MNKD:NASDAQ
MannKind Corp
$3.10
arrow_upward
+0.16%(+0.0050) 1D
Oct 20, 12:15:40 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MNKD...
Open
$3.11
High
$3.18
Low
$3.08
Mkt. cap
995.18M
Avg. vol.
4.97M
Volume
863.69K
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.09
Shares outstanding
321.54M
No. of employees
592
Open
$3.11
High
$3.18
Low
$3.08
Mkt. cap
995.18M
Avg. vol.
4.97M
Volume
863.69K
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.09
Shares outstanding
321.54M
No. of employees
592
News stories
From web sources and news partners
GuruFocus
·
4 hours ago
MNKD Reiterated by Cantor Fitzgerald -- Price Target Maintained at $8.00
Yahoo Finance
·
13 hours ago
Learn Why The Bull Case For MannKind Stock Could Change Following Outpatient Diuretic Data
Investing.com
·
1 day ago
Chardan initiates MannKind stock coverage with buy rating on pipeline
Profile
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
About MannKind Corp
CEOMichael Castagna
Employees592
FoundedFeb 1991
HeadquartersDanbury, Connecticut, United States
SectorBiotechnology
Websitemannkindcorp.com